Abstract: A system, method and graphical user interface display for validating, monitoring and otherwise reviewing the sales and distribution of medicines, to reduce the instances of counterfeit medicines. A pharmaceutical company provides medicines to users, either directly or through representatives for the pharmaceutical company. The products have associated identifying codes that are used to track the sales of the products. The system provides verifications of the medicines, as well as statistical analysis of the sales and distribution. The verifications and comparisons of the distribution and sales of the medicines can be reviewed by the user or on a dashboard user interface. The system further allows pharmaceutical companies provided the medicines to provide response messages to users.